1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Virginia Catalyst Grant Program is sponsored by Virginia Catalyst. This program provides non-dilutive grants to foster collaborations between Virginia research universities and industry in life sciences and biosciences. The goal is to accelerate translational research and commercialization of innovations that address unmet medical needs and drive economic development in Virginia.
Projects must demonstrate substantive collaboration between at least two of the five Virginia research institutions: University of Virginia, Virginia Commonwealth University, Virginia Tech, George Mason University, and Old Dominion University.
Get alerted about grants like this
Get emailed when new opportunities from “Virginia Catalyst” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
strength through collaboration Our Strategic Initiatives - Actions and Results for Virginia At the Virginia Catalyst we specialize in developing and leading strategic initiatives in areas were Virginia can be a national and global leader.
We support these initiatives with grant funding for collaborative projects, investments creating research tools, and infrastructure that provide our research universities, healthcare systems and companies a competitive advantage over other regions in the country. Our goal is to have the Commonwealth of Virginia be the very best in the nation at translational medicine and commercialization.
We will achieve this by teaming up the biosciences industry with our world-class academic researchers and focusing efforts on solving large unmet medical needs.
Continuing powerful impact through our Grant Funding Program Funding through our Grant Funding Program is designed to facilitate the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy. Virginia Catalyst awards these funds to help accelerate translational research and the commercialization of Virginia’s innovations.
The awards, which range from $200,000 to $800,000, help fund collaborative efforts between industry and Virginia research universities. Learn more about our Grant Funding Program Special Webinar - How to Score High and Get Funding Previously the Virginia Catalyst and Virginia Bio co-hosted a special webinar that featured a panel of experts sharing what it takes to score highly and get funding.
Mike Grisham , President and CEO, Virginia Catalyst, Founder and CEO, GPB Scientific, Inc. Mickey Kim , former Senior Vice President, Research and Commercialization, Inova Translational Medicine Institute J ames Powers , Chairman and CEO, HemoShear Theapeutics, LLC Thomas D.
Roberts III , General Partner, Harbert Growth Partners, Harbert Management Corporation Read the full press release here Download the presentation slides We are a not-for-profit 501(c)(3) corporation created by the Virginia General Assembly and funded by the Commonwealth’s General Fund and five Virginia public research universities: George Mason University, Old Dominion University (with Eastern Virginia Medical School) , University of Virginia, Virginia Commonwealth University, and Virginia Tech.
Our mission is to advance economic development by creating competitive critical mass for Virginia life sciences through collaborations with our research universities and industry, to attract research and commercialization capital to Virginia and to catalyze the commercialization of Virginia’s innovations that meet large, unmet medical needs, improve human health and to create many more high-paying life science jobs in Virginia.
According to the current listing, eligibility includes: Projects must demonstrate substantive collaboration between at least two of the universities that make up the research consortium: University of Virginia, Virginia Commonwealth University, Virginia Tech, George Mason University, and Old Dominion University. The grants are for companies at the forefront of biomedical innovation. Confirm the full requirements in the official notice before applying.
The current listing shows $200,000 to $800,000 (awards often up to $800,000, with recent rounds totaling $2.4 million). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Virginia Catalyst Grant Program is funded by Virginia Catalyst. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Virginia. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.